(PhysOrg.com) -- Researchers led by University of Massachusetts Amherst chemist Vincent Rotello have demonstrated that they can deliver a dormant toxin into a specific site such as a tumor for anti-cancer therapy, then chemically ...
Biochemistry
Oct 4, 2010
5
0
Scientists have determined that Helicobacter pylori, the bacterium that causes peptic ulcers and some forms of stomach cancer, requires the vitamin B6 to establish and maintain chronic infection, according to research published ...
Cell & Microbiology
Aug 19, 2010
0
0
Studies led by Stony Brook University professor of chemistry Peter J. Tonge indicate that modifications that enhance the time a drug remains bound to its target, or residence time, may lead to better diagnostic and therapeutic ...
Biochemistry
Apr 25, 2010
0
0
The quest for new drugs is generally a lengthy and costly undertaking. German researchers of Ludwig-Maximilians-Universitaet in Munich have now come up with a simpler and more efficient way of going about it. Not only pharmaceutical ...
Biochemistry
Feb 24, 2010
0
0
(PhysOrg.com) -- One of the great promises of nanotechnologies lies in its ability to create drug-containing nanoparticles decorated with targeting molecules that recognize and bind to cancer cells, providing drug delivery ...
Bio & Medicine
Nov 20, 2009
0
0
A team of international molecular scientists, led by a Monash University researcher has discovered a new, fast mechanism by which cells communicate change - for example their location during spreading of a cancer in the human ...
Cell & Microbiology
Oct 14, 2009
0
0
Clemson bioengineer Frank Alexis is designing new ways to target drugs and reduce the chances for side effects.
Bio & Medicine
Oct 8, 2009
0
0
When it comes to solving complex problems, Geoffrey von Maltzahn, MIT graduate student and biomedical engineer, looks to nature for solutions. Finding inspiration in systems that evolution has produced, von Maltzahn is currently ...
Bio & Medicine
Mar 3, 2009
5
0
